Omar M M, Fakhry S M, Mostafa I
Division of Clinical Tropical Medicine, Theodore Bilharz Research Institute, Giza, Egypt.
J Egypt Soc Parasitol. 1998 Apr;28(1):159-68.
The present study was conducted to compare usual sclerosants: polidocanol 1%, ethanolamine oleate 5% and the tissue adhesive: cyanoacrylate in the control of oesophageal variceal bleeding in Egyptian patients with portal hypertension in a prospective comparative trial. Sixty patients with portal hypertension due to schistosomal hepatic fibrosis and/or posthepatitic liver cirrhosis who had presented with acute oesophageal variceal bleeding were enrolled. Patients received balloon tamponade prior to injection were excluded. Resuscitation had been done before or during emergency endoscopy. Emergency endoscopy was conducted within 2 hours from the onset of hematemesis. Patients were immediately randomized during emergency endoscopy to receive polidocanol 1%, ethanolamine oleate 5% or tissue adhesive. Variceal rebleeding was managed by reinjection. The three groups were comparable for age, sex, etiology of portal hypertension, Child-Pugh class and findings at emergency endoscopy. No active bleeding was observed at the end of all injection sessions. Rebleeding had been occurred within the first 24 hours in 2 (10%) patients in polidocanol group and 3 (15%) patients in ethanolamine group (P > 0.05). Reinjection did control rebleeding in 2 (10%) patients in ethanolamine group with a total success rate of 95%. Exsanguinating rebleeding occurred in 2 (10%) patients in polidocanol group and one (5%) patient in ethanolamine group (P > 0.05). Postinjection large ulcers were diagnosed either in polidocanol (15%) or ethanolamine (10%) groups (P > 0.05). Other complications were minor and showed no significant differences between the three groups. In coclusion, polidocanol, ethanolamine and cyanoacrylate are equally safe and effective. For immediate endoscopic injection therapy an experienced team must be available.
本研究通过一项前瞻性对比试验,比较常用硬化剂(1%聚多卡醇、5%油酸乙醇胺)和组织粘合剂(氰基丙烯酸酯)对埃及门静脉高压患者食管静脉曲张出血的控制效果。纳入60例因血吸虫性肝纤维化和/或肝炎后肝硬化导致门静脉高压并出现急性食管静脉曲张出血的患者。排除在注射前接受过气囊压迫的患者。在急诊内镜检查之前或期间进行了复苏。在呕血发作后2小时内进行急诊内镜检查。患者在急诊内镜检查期间立即随机分组,分别接受1%聚多卡醇、5%油酸乙醇胺或组织粘合剂治疗。静脉曲张再出血通过再次注射进行处理。三组在年龄、性别、门静脉高压病因、Child-Pugh分级和急诊内镜检查结果方面具有可比性。在所有注射疗程结束时均未观察到活动性出血。聚多卡醇组有2例(10%)患者在最初24小时内发生再出血,油酸乙醇胺组有3例(15%)患者发生再出血(P>0.05)。油酸乙醇胺组有2例(10%)患者通过再次注射控制了再出血,总成功率为95%。聚多卡醇组有2例(10%)患者发生失血性再出血,油酸乙醇胺组有1例(5%)患者发生失血性再出血(P>0.05)。聚多卡醇组(15%)或油酸乙醇胺组(10%)诊断出注射后大溃疡(P>0.05)。其他并发症较轻,三组之间无显著差异。总之,聚多卡醇、油酸乙醇胺和氰基丙烯酸酯同样安全有效。对于即时内镜注射治疗,必须有经验丰富的团队。